Get started
AIDA PHARMA INCAA

AIDA PHARMA INC

0.0002USDD
0.00000.00%
At close at Dec 18, 2024, 20:40 GMT
USD
No trades
See on Supercharts
Overview
Financials
Discussions Technicals Seasonals

AIDA fundamentals

Key facts

Market capitalization‪5.40 K‬USD
Dividend yield (indicated)—
Price to earnings Ratio (TTM)—
Basic EPS (TTM)—
Founded2002
Employees (FY)—
CEOBiao Jin
Website—
About

AiDa Pharmaceuticals, Inc. engages in the development, production, and distribution of pharmaceutical products. It offers Etimicin Sulfate, an antibiotic, which treats respiratory infection, kidney and urinogenital infection, soft skin tissue infection, and trauma and operations preventive uses. The company was founded on December 18, 2002 and is headquartered in Hangzhou, China.

Ownership
‪‪27.00 M‬‬
Closely held shares
‪‪20.37 M‬‬ (75.44%)
Free Float shares
‪‪6.63 M‬‬ (24.56%)
Closely held shares
‪‪20.37 M‬‬ (75.44%)
Free Float shares
‪‪6.63 M‬‬ (24.56%)
Capital structure
No data available
There's currently no data to show about this capital structure.

Valuation

Fundamental metrics to determine fair value of the stock

Summary
‪‪5.40 K‬‬
Price to earning ratio (P/E)
—
Price to sales ratio (P/S)
—
Market Cap
Net income
Revenue
Price to earning ratio (P/E)
—
Price to sales ratio (P/S)
—
Valuation ratios
2019
2020
2021
2022
2023

Growth and Profitability

Company’s recent performance and margins

Performance
Revenue
Net income
Net margin %
Revenue to profit conversion
No data available
There's currently no revenue data to show for the selected period.

Dividends

Dividend yield, history and sustainability

AIDA does not pay dividends
The company has not previously paid dividends and at the moment there is no information about whether it is going to pay them in the future

Financial health

Financial position and solvency of the company

Debt level and coverage
2019
2020
2021
2022
2023
Debt
Free cash flow
Cash & equivalents
Financial position analysis
No data available
There's currently no assets and liabilities data to show.